Jaguar Health, Inc.

Jaguar Health, Inc.verified

JAGX

Price:

$4.63

Market Cap:

$22.64M

Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic, and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It markets Mytesi for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. The company also develops Crofelemer for multiple possible follow-on indications, including cancer therapy-related diarrhea; orphan-drug indications for symptomatic relief of diarrhea in infants and children with congenital diarrheal disorders and for adult and pediatric patients for shor...[Read more]

Industry

Biotechnology

IPO Date

2015-05-12

Stock Exchange

NASDAQ

Ticker

JAGX

The PE Ratio as of May 2024 (TTM) for Jaguar Health, Inc. (JAGX) is 0.14

According to Jaguar Health, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 0.14. This represents a change of -101.34% compared to the average of -10.45 of the last 4 quarters.

Jaguar Health, Inc. (JAGX) Historical PE Ratio (quarterly & annually)

How has JAGX PE Ratio performed in the past?

The mean historical PE Ratio of Jaguar Health, Inc. over the last ten years is -79.26. The current 0.14 PE Ratio has changed -117.66% with respect to the historical average. Over the past ten years (40 quarters), JAGX's PE Ratio was at its highest in in the September 2017 quarter at 97.05. The PE Ratio was at its lowest in in the June 2014 quarter at -536.01.

Quarterly (TTM)
Annual

Average

-79.26

Median

-43.47

Minimum

-484.05

Maximum

-0.08

Jaguar Health, Inc. (JAGX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Jaguar Health, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 729.49%

Maximum Annual PE Ratio = -0.08

Minimum Annual Increase = -Infinity%

Minimum Annual PE Ratio = -484.05

Quarterly (TTM)
Annual
YearPE RatioChange
2023-0.08-99.22%
2022-10.81-76.66%
2021-46.31-9.85%
2020-51.37729.49%
2019-6.19-55.59%
2018-13.94-80.82%
2017-72.7078.94%
2016-40.63-38.97%
2015-66.56-86.25%
2014-484.05-Infinity%

Jaguar Health, Inc. (JAGX) Average PE Ratio

How has JAGX PE Ratio performed in the past?

The current PE Ratio of Jaguar Health, Inc. (JAGX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-19.07

5-year avg

-22.95

10-year avg

-79.26

Jaguar Health, Inc. (JAGX) PE Ratio vs. Peers

How is JAGX’s PE Ratio compared to its peers?

Jaguar Health, Inc.’s PE Ratio is greater than Onconova Therapeutics, Inc. (-1.15), greater than iBio, Inc. (-0.35), greater than GeoVax Labs, Inc. (-0.15), greater than Ocugen, Inc. (-7.69), greater than eFFECTOR Therapeutics, Inc. (-0.21), greater than Virios Therapeutics, Inc. (-0.80), greater than Zura Bio Limited (-5.00), greater than Navidea Biopharmaceuticals, Inc. (-0.00), greater than ZyVersa Therapeutics, Inc. (-0.03), greater than Tonix Pharmaceuticals Holding Corp. (-0.14), greater than Acasti Pharma Inc. (-0.80), greater than Diffusion Pharmaceuticals Inc. (-0.00), greater than Phio Pharmaceuticals Corp. (-0.37), greater than Sonnet BioTherapeutics Holdings, Inc. (-0.90), greater than 180 Life Sciences Corp. (-0.06), greater than Cardio Diagnostics Holdings, Inc. (-1.26), greater than Vaxart, Inc. (-1.79), greater than VBI Vaccines Inc. (-0.19),

Build a custom stock screener for Jaguar Health, Inc. (JAGX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Jaguar Health, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Jaguar Health, Inc. (JAGX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Jaguar Health, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Jaguar Health, Inc.'s PE Ratio?

How is the PE Ratio calculated for Jaguar Health, Inc. (JAGX)?

What is the highest PE Ratio for Jaguar Health, Inc. (JAGX)?

What is the 3-year average PE Ratio for Jaguar Health, Inc. (JAGX)?

What is the 5-year average PE Ratio for Jaguar Health, Inc. (JAGX)?

How does the current PE Ratio for Jaguar Health, Inc. (JAGX) compare to its historical average?